Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor-risk MDS/AML
Year: 2025
Type: article
Language: en
Topic: Acute Myeloid Leukemia Research
Authors and affiliations:
raw_author_name: Jacqueline S. Garcia
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Haesook T. Kim
raw_affiliation_strings: 2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Inst., Boston, Massachusetts, United States
raw_author_name: H. Moses Murdock
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Anna Bosch-Vilaseca
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Kevin M. Panaro
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Felicia Lim
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Jade Fiorilla
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Elise Auriemma
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Jennifer Brock
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Mahasweta Gooptu
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana- Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Vincent T. Ho
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Corey S. Cutler
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Roman Shapiro
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Amar H. Kelkar
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Gregory A. Abel
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Daniel J. DeAngelo
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Richard M. Stone
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Denbaa Bat-Erdene
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Jeremy Ryan
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Geoffrey Fell
raw_affiliation_strings: 2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Anthony Letai
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Jerome Ritz
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: R. Coleman Lindsley
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Joseph H. Antin
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
raw_author_name: Robert J. Soiffer
raw_affiliation_strings: 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute, BOSTON, Massachusetts, United States